Related Experiment Video

Updated: Sep 27, 2026

An In Vitro Model for Measuring Immune Responses to Malaria in the Context of HIV Co-infection
08:14

An In Vitro Model for Measuring Immune Responses to Malaria in the Context of HIV Co-infection

Published on: October 6, 2015

HIV-infected inpatients in the HAART era: how do hepatitis C virus coinfected patients differ?

Oluwatoyin M Falusi1, Joseph Pulvirenti, Julia Sarazine

  • 1Cook County Hospital and Rush Medical College, Chicago, Illinois 60612, USA. tfalusi@hotmail.com

AIDS Patient Care and Stds
|March 5, 2003
PubMed

Insights

Hepatitis C virus (HCV) coinfection in HIV patients was common, with these individuals less likely to receive highly active antiretroviral therapy (HAART). They often required hospitalization for liver disease complications, even with higher CD4 counts.

Area of Science:

  • Infectious Diseases
  • Hepatology
  • Public Health

Background:

  • HIV and Hepatitis C Virus (HCV) are significant global health concerns.
  • Coinfection presents unique challenges in patient management and outcomes.
  • Understanding demographic and clinical differences is crucial for targeted interventions.

Purpose of the Study:

  • To compare the characteristics of HIV-infected patients with and without HCV coinfection.
  • To identify differences in treatment and reasons for hospitalization between coinfected and non-coinfected groups.
  • To inform clinical practice and public health strategies for managing coinfected individuals.

Main Methods:

  • Retrospective cohort study of hospitalized patients.
  • Inclusion criteria: HIV-infected patients from October 1999 to September 2000.
  • Data collection: Demographics, clinical characteristics, HCV coinfection status, HAART use, CD4 counts, and reasons for hospitalization.

Main Results:

  • 40% of 510 HIV-infected patients were coinfected with HCV.
  • HCV coinfected patients were less likely to be on highly active antiretroviral therapy (HAART).
  • HCV coinfected patients had higher CD4 counts and were hospitalized for non-HIV-related issues, including liver disease complications.

Conclusions:

  • HCV coinfection is prevalent among hospitalized HIV patients.
  • HCV coinfected patients may receive less HAART and face distinct hospitalization patterns.
  • Complications of liver disease are a significant concern for HIV/HCV coinfected individuals.

More Related Videos

Humanized NOD/SCID/IL2rγnull (hu-NSG) Mouse Model for HIV Replication and Latency Studies07:10

Humanized NOD/SCID/IL2rγnull (hu-NSG) Mouse Model for HIV Replication and Latency Studies

Published on: January 7, 2019

Related Concept Videos

Retrovirus Life Cycles01:10

Retrovirus Life Cycles

Retroviruses have a single-stranded RNA genome that undergoes a special form of replication. Once the retrovirus has entered the host cell, an enzyme called reverse transcriptase synthesizes double-stranded DNA from the retroviral RNA genome. This DNA copy of the genome is then integrated into the host’s genome inside the nucleus via an enzyme called integrase. Consequently, the retroviral genome is transcribed into RNA whenever the host’s genome is transcribed, allowing the retrovirus to...
Hepatitis01:25

Hepatitis

Hepatitis is an inflammatory condition of the liver most commonly caused by hepatotropic viruses (A–E), though non-infectious causes such as alcohol and drugs also exist.Hepatitis AHepatitis A virus (HAV) is a non-enveloped RNA virus of the Picornaviridae family. It is primarily transmitted via the fecal-oral route, typically through ingestion of contaminated food or water. After ingestion, HAV enters the bloodstream through the oropharynx or intestinal epithelium and reaches the liver. The...
Sexually Transmitted Infections01:26

Sexually Transmitted Infections

Sexually transmitted infections (STIs) are diseases transmitted primarily through unsafe sexual interactions. Bacteria, viruses, or parasites cause them and can result in severe health complications if untreated.ChlamydiaThe bacterium Chlamydia trachomatis is responsible for the disease Chlamydia, the most common STI in the United States. This peculiar pathogen requires human cells to reproduce, residing intracellularly. The initial infection often goes unnoticed because it typically does not...
Healthcare Associated Infections II: Preventive Measures01:22

Healthcare Associated Infections II: Preventive Measures

Essential infection prevention measures are based on the knowledge of the infection chain, the modes of transmission in healthcare settings, and the use of the best practices in all healthcare settings. Compulsory public reporting of healthcare-associated infection rates is needed to allow individuals and the community to make informed choices regarding selecting a healthcare facility.
The best practices for preventing healthcare-associated infections include hand hygiene, patient risk...
Cryptococcal Meningitis01:27

Cryptococcal Meningitis

Cryptococcal meningitis is a life-threatening opportunistic infection predominantly associated with HIV/AIDS, accounting for over 100,000 deaths annually worldwide. However, it also affects individuals with other forms of immunosuppression, including those undergoing immunosuppressive therapy, organ transplant recipients, patients with innate immunodeficiencies, and individuals with hematological disorders. The infection is caused mainly by Cryptococcus neoformans and Cryptococcus gattii,...
Pulmonary Tuberculosis I01:29

Pulmonary Tuberculosis I

Tuberculosis, often called TB, is a contagious illness primarily caused by Mycobacterium tuberculosis. It mainly affects the lung parenchyma but can also impact other body parts.
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...